At the news
? BULLISHIMPACT 6/10 PRESS-RELEASE filed Jul 2, 2026 at 09:25 ET
MacroGenics completed the sale of its GMP manufacturing operations to Bora Pharmaceuticals for $122.5 million, transitioning to an asset-light R&D model and securing cash to fund its pipeline. The deal includes a supply agreement for continued production support.
- Sale of GMP drug substance manufacturing operations to Bora Pharmaceuticals for $122.5 million
- Approximately 140 employees transferred to Bora
- Supply agreement signed for process development and production for MacroGenics' pipeline
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access